Exosome reduction invivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease

Michael B. Dinkins, Somsankar Dasgupta, Guanghu Wang, Gu Zhu, Erhard Bieberich

Research output: Contribution to journalArticle

119 Citations (Scopus)

Abstract

We present evidence here that exosomes stimulate aggregation of amyloid beta (Aβ)1-42 invitro and invivo and interfere with uptake of Aβ by primary cultured astrocytes and microglia invitro. Exosome secretion is prevented by the inhibition of neutral sphingomyelinase 2 (nSMase2), a key regulatory enzyme generating ceramide from sphingomyelin, with GW4869. Using the 5XFAD mouse, we show that intraperitoneal injection of GW4869 reduces the levels of brain and serum exosomes, brain ceramide, and Aβ1-42 plaque load. Reduction of total Aβ1-42 as well as number of plaques in brain sections was significantly greater (40% reduction) in male than female mice. Our results suggest that GW4869 reduces amyloid plaque formation invivo by preventing exosome secretion and identifies nSMase2 as a potential drug target in AD by interfering with exosome secretion.

Original languageEnglish (US)
Pages (from-to)1792-1800
Number of pages9
JournalNeurobiology of Aging
Volume35
Issue number8
DOIs
StatePublished - Jan 1 2014

Fingerprint

Exosomes
Amyloid Plaques
Alzheimer Disease
Sphingomyelin Phosphodiesterase
Ceramides
Brain
Sphingomyelins
Microglia
Intraperitoneal Injections
Astrocytes
Enzymes
Serum
Pharmaceutical Preparations
GW 4869

Keywords

  • Alzheimer's disease
  • Amyloid beta
  • Astrocytes
  • Exosomes
  • GW4869
  • Neutral sphingomyelinase
  • Primary culture

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)
  • Aging
  • Developmental Biology
  • Geriatrics and Gerontology
  • Medicine(all)

Cite this

Exosome reduction invivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease. / Dinkins, Michael B.; Dasgupta, Somsankar; Wang, Guanghu; Zhu, Gu; Bieberich, Erhard.

In: Neurobiology of Aging, Vol. 35, No. 8, 01.01.2014, p. 1792-1800.

Research output: Contribution to journalArticle

Dinkins, Michael B. ; Dasgupta, Somsankar ; Wang, Guanghu ; Zhu, Gu ; Bieberich, Erhard. / Exosome reduction invivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease. In: Neurobiology of Aging. 2014 ; Vol. 35, No. 8. pp. 1792-1800.
@article{196f36538377408d89cd50bec006bfbd,
title = "Exosome reduction invivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease",
abstract = "We present evidence here that exosomes stimulate aggregation of amyloid beta (Aβ)1-42 invitro and invivo and interfere with uptake of Aβ by primary cultured astrocytes and microglia invitro. Exosome secretion is prevented by the inhibition of neutral sphingomyelinase 2 (nSMase2), a key regulatory enzyme generating ceramide from sphingomyelin, with GW4869. Using the 5XFAD mouse, we show that intraperitoneal injection of GW4869 reduces the levels of brain and serum exosomes, brain ceramide, and Aβ1-42 plaque load. Reduction of total Aβ1-42 as well as number of plaques in brain sections was significantly greater (40{\%} reduction) in male than female mice. Our results suggest that GW4869 reduces amyloid plaque formation invivo by preventing exosome secretion and identifies nSMase2 as a potential drug target in AD by interfering with exosome secretion.",
keywords = "Alzheimer's disease, Amyloid beta, Astrocytes, Exosomes, GW4869, Neutral sphingomyelinase, Primary culture",
author = "Dinkins, {Michael B.} and Somsankar Dasgupta and Guanghu Wang and Gu Zhu and Erhard Bieberich",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.neurobiolaging.2014.02.012",
language = "English (US)",
volume = "35",
pages = "1792--1800",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Exosome reduction invivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease

AU - Dinkins, Michael B.

AU - Dasgupta, Somsankar

AU - Wang, Guanghu

AU - Zhu, Gu

AU - Bieberich, Erhard

PY - 2014/1/1

Y1 - 2014/1/1

N2 - We present evidence here that exosomes stimulate aggregation of amyloid beta (Aβ)1-42 invitro and invivo and interfere with uptake of Aβ by primary cultured astrocytes and microglia invitro. Exosome secretion is prevented by the inhibition of neutral sphingomyelinase 2 (nSMase2), a key regulatory enzyme generating ceramide from sphingomyelin, with GW4869. Using the 5XFAD mouse, we show that intraperitoneal injection of GW4869 reduces the levels of brain and serum exosomes, brain ceramide, and Aβ1-42 plaque load. Reduction of total Aβ1-42 as well as number of plaques in brain sections was significantly greater (40% reduction) in male than female mice. Our results suggest that GW4869 reduces amyloid plaque formation invivo by preventing exosome secretion and identifies nSMase2 as a potential drug target in AD by interfering with exosome secretion.

AB - We present evidence here that exosomes stimulate aggregation of amyloid beta (Aβ)1-42 invitro and invivo and interfere with uptake of Aβ by primary cultured astrocytes and microglia invitro. Exosome secretion is prevented by the inhibition of neutral sphingomyelinase 2 (nSMase2), a key regulatory enzyme generating ceramide from sphingomyelin, with GW4869. Using the 5XFAD mouse, we show that intraperitoneal injection of GW4869 reduces the levels of brain and serum exosomes, brain ceramide, and Aβ1-42 plaque load. Reduction of total Aβ1-42 as well as number of plaques in brain sections was significantly greater (40% reduction) in male than female mice. Our results suggest that GW4869 reduces amyloid plaque formation invivo by preventing exosome secretion and identifies nSMase2 as a potential drug target in AD by interfering with exosome secretion.

KW - Alzheimer's disease

KW - Amyloid beta

KW - Astrocytes

KW - Exosomes

KW - GW4869

KW - Neutral sphingomyelinase

KW - Primary culture

UR - http://www.scopus.com/inward/record.url?scp=84899968840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899968840&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2014.02.012

DO - 10.1016/j.neurobiolaging.2014.02.012

M3 - Article

C2 - 24650793

AN - SCOPUS:84899968840

VL - 35

SP - 1792

EP - 1800

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 8

ER -